Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016604 | nuclear body | 2 | 12 |
GO:0016605 | PML body | 3 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005634 | nucleus | 5 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HTT2
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0016567 | protein ubiquitination | 7 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0032446 | protein modification by small protein conjugation | 6 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:0006508 | proteolysis | 4 | 1 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009057 | macromolecule catabolic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 1 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0046872 | metal ion binding | 4 | 12 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004842 | ubiquitin-protein transferase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0019787 | ubiquitin-like protein transferase activity | 3 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 150 | 154 | PF00656 | 0.613 |
CLV_C14_Caspase3-7 | 277 | 281 | PF00656 | 0.577 |
CLV_C14_Caspase3-7 | 292 | 296 | PF00656 | 0.520 |
CLV_C14_Caspase3-7 | 329 | 333 | PF00656 | 0.271 |
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.344 |
CLV_NRD_NRD_1 | 251 | 253 | PF00675 | 0.592 |
CLV_NRD_NRD_1 | 461 | 463 | PF00675 | 0.439 |
CLV_NRD_NRD_1 | 476 | 478 | PF00675 | 0.246 |
CLV_NRD_NRD_1 | 521 | 523 | PF00675 | 0.484 |
CLV_PCSK_KEX2_1 | 116 | 118 | PF00082 | 0.395 |
CLV_PCSK_KEX2_1 | 251 | 253 | PF00082 | 0.501 |
CLV_PCSK_KEX2_1 | 275 | 277 | PF00082 | 0.552 |
CLV_PCSK_KEX2_1 | 461 | 463 | PF00082 | 0.439 |
CLV_PCSK_KEX2_1 | 476 | 478 | PF00082 | 0.241 |
CLV_PCSK_KEX2_1 | 490 | 492 | PF00082 | 0.257 |
CLV_PCSK_KEX2_1 | 521 | 523 | PF00082 | 0.476 |
CLV_PCSK_PC1ET2_1 | 275 | 277 | PF00082 | 0.517 |
CLV_PCSK_PC1ET2_1 | 490 | 492 | PF00082 | 0.321 |
CLV_PCSK_PC1ET2_1 | 521 | 523 | PF00082 | 0.476 |
CLV_PCSK_SKI1_1 | 117 | 121 | PF00082 | 0.341 |
CLV_PCSK_SKI1_1 | 123 | 127 | PF00082 | 0.288 |
CLV_PCSK_SKI1_1 | 131 | 135 | PF00082 | 0.161 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.298 |
DEG_APCC_DBOX_1 | 99 | 107 | PF00400 | 0.391 |
DOC_CDC14_PxL_1 | 50 | 58 | PF14671 | 0.496 |
DOC_CYCLIN_yCln2_LP_2 | 38 | 44 | PF00134 | 0.526 |
DOC_MAPK_gen_1 | 116 | 126 | PF00069 | 0.252 |
DOC_MAPK_gen_1 | 302 | 311 | PF00069 | 0.546 |
DOC_MAPK_RevD_3 | 101 | 117 | PF00069 | 0.384 |
DOC_PP2B_LxvP_1 | 33 | 36 | PF13499 | 0.569 |
DOC_PP4_FxxP_1 | 190 | 193 | PF00568 | 0.343 |
DOC_PP4_FxxP_1 | 334 | 337 | PF00568 | 0.309 |
DOC_USP7_MATH_1 | 137 | 141 | PF00917 | 0.570 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.592 |
DOC_USP7_MATH_1 | 347 | 351 | PF00917 | 0.368 |
DOC_USP7_MATH_1 | 420 | 424 | PF00917 | 0.314 |
DOC_USP7_MATH_1 | 7 | 11 | PF00917 | 0.763 |
DOC_WW_Pin1_4 | 11 | 16 | PF00397 | 0.664 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.693 |
DOC_WW_Pin1_4 | 324 | 329 | PF00397 | 0.391 |
DOC_WW_Pin1_4 | 454 | 459 | PF00397 | 0.343 |
LIG_14-3-3_CanoR_1 | 192 | 197 | PF00244 | 0.284 |
LIG_14-3-3_CanoR_1 | 224 | 232 | PF00244 | 0.399 |
LIG_14-3-3_CanoR_1 | 235 | 244 | PF00244 | 0.547 |
LIG_14-3-3_CanoR_1 | 344 | 352 | PF00244 | 0.391 |
LIG_14-3-3_CanoR_1 | 462 | 468 | PF00244 | 0.457 |
LIG_14-3-3_CanoR_1 | 477 | 485 | PF00244 | 0.478 |
LIG_APCC_ABBA_1 | 388 | 393 | PF00400 | 0.329 |
LIG_APCC_ABBA_1 | 56 | 61 | PF00400 | 0.332 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.632 |
LIG_deltaCOP1_diTrp_1 | 428 | 437 | PF00928 | 0.217 |
LIG_EVH1_2 | 401 | 405 | PF00568 | 0.343 |
LIG_FHA_1 | 180 | 186 | PF00498 | 0.278 |
LIG_FHA_1 | 231 | 237 | PF00498 | 0.376 |
LIG_FHA_1 | 53 | 59 | PF00498 | 0.432 |
LIG_FHA_1 | 96 | 102 | PF00498 | 0.313 |
LIG_Integrin_isoDGR_2 | 114 | 116 | PF01839 | 0.304 |
LIG_Integrin_isoDGR_2 | 158 | 160 | PF01839 | 0.524 |
LIG_LIR_Apic_2 | 188 | 193 | PF02991 | 0.394 |
LIG_LIR_Apic_2 | 332 | 337 | PF02991 | 0.264 |
LIG_LIR_Gen_1 | 162 | 171 | PF02991 | 0.386 |
LIG_LIR_Gen_1 | 395 | 405 | PF02991 | 0.279 |
LIG_LIR_Nem_3 | 162 | 168 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 386 | 391 | PF02991 | 0.431 |
LIG_LIR_Nem_3 | 395 | 400 | PF02991 | 0.217 |
LIG_LIR_Nem_3 | 466 | 471 | PF02991 | 0.312 |
LIG_PCNA_PIPBox_1 | 412 | 421 | PF02747 | 0.249 |
LIG_SH2_CRK | 50 | 54 | PF00017 | 0.515 |
LIG_SH2_STAT3 | 163 | 166 | PF00017 | 0.392 |
LIG_SH2_STAT5 | 243 | 246 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 418 | 421 | PF00017 | 0.249 |
LIG_SH3_3 | 396 | 402 | PF00018 | 0.440 |
LIG_TRAF2_1 | 253 | 256 | PF00917 | 0.489 |
LIG_UBA3_1 | 164 | 169 | PF00899 | 0.457 |
MOD_CDK_SPK_2 | 3 | 8 | PF00069 | 0.606 |
MOD_CDK_SPxxK_3 | 11 | 18 | PF00069 | 0.631 |
MOD_CDK_SPxxK_3 | 454 | 461 | PF00069 | 0.279 |
MOD_CK1_1 | 279 | 285 | PF00069 | 0.606 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.623 |
MOD_CK1_1 | 406 | 412 | PF00069 | 0.347 |
MOD_CK2_1 | 235 | 241 | PF00069 | 0.426 |
MOD_Cter_Amidation | 114 | 117 | PF01082 | 0.346 |
MOD_DYRK1A_RPxSP_1 | 454 | 458 | PF00069 | 0.279 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.577 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.577 |
MOD_GlcNHglycan | 208 | 211 | PF01048 | 0.396 |
MOD_GlcNHglycan | 345 | 348 | PF01048 | 0.329 |
MOD_GlcNHglycan | 405 | 408 | PF01048 | 0.441 |
MOD_GlcNHglycan | 430 | 433 | PF01048 | 0.372 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.487 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.290 |
MOD_GSK3_1 | 104 | 111 | PF00069 | 0.285 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.537 |
MOD_GSK3_1 | 270 | 277 | PF00069 | 0.521 |
MOD_GSK3_1 | 291 | 298 | PF00069 | 0.533 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.632 |
MOD_GSK3_1 | 343 | 350 | PF00069 | 0.279 |
MOD_GSK3_1 | 380 | 387 | PF00069 | 0.376 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.448 |
MOD_N-GLC_1 | 108 | 113 | PF02516 | 0.249 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.298 |
MOD_NEK2_1 | 343 | 348 | PF00069 | 0.425 |
MOD_NEK2_2 | 297 | 302 | PF00069 | 0.545 |
MOD_NEK2_2 | 347 | 352 | PF00069 | 0.279 |
MOD_NEK2_2 | 463 | 468 | PF00069 | 0.343 |
MOD_OFUCOSY | 345 | 351 | PF10250 | 0.279 |
MOD_PK_1 | 192 | 198 | PF00069 | 0.343 |
MOD_PKA_2 | 175 | 181 | PF00069 | 0.450 |
MOD_PKA_2 | 223 | 229 | PF00069 | 0.450 |
MOD_PKA_2 | 230 | 236 | PF00069 | 0.308 |
MOD_PKA_2 | 343 | 349 | PF00069 | 0.329 |
MOD_PKA_2 | 7 | 13 | PF00069 | 0.672 |
MOD_Plk_4 | 108 | 114 | PF00069 | 0.249 |
MOD_Plk_4 | 185 | 191 | PF00069 | 0.304 |
MOD_Plk_4 | 192 | 198 | PF00069 | 0.266 |
MOD_Plk_4 | 420 | 426 | PF00069 | 0.304 |
MOD_Plk_4 | 463 | 469 | PF00069 | 0.305 |
MOD_ProDKin_1 | 11 | 17 | PF00069 | 0.663 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.693 |
MOD_ProDKin_1 | 324 | 330 | PF00069 | 0.391 |
MOD_ProDKin_1 | 454 | 460 | PF00069 | 0.343 |
MOD_SUMO_for_1 | 119 | 122 | PF00179 | 0.384 |
MOD_SUMO_for_1 | 168 | 171 | PF00179 | 0.488 |
MOD_SUMO_for_1 | 435 | 438 | PF00179 | 0.369 |
TRG_DiLeu_BaEn_4 | 255 | 261 | PF01217 | 0.447 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.499 |
TRG_ENDOCYTIC_2 | 513 | 516 | PF00928 | 0.435 |
TRG_ER_diArg_1 | 116 | 118 | PF00400 | 0.304 |
TRG_ER_diArg_1 | 174 | 177 | PF00400 | 0.543 |
TRG_ER_diArg_1 | 251 | 253 | PF00400 | 0.578 |
TRG_ER_diArg_1 | 475 | 477 | PF00400 | 0.301 |
TRG_Pf-PMV_PEXEL_1 | 477 | 482 | PF00026 | 0.454 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P377 | Leptomonas seymouri | 63% | 98% |
A0A0S4JT63 | Bodo saltans | 42% | 100% |
A0A1X0NPC5 | Trypanosomatidae | 45% | 99% |
A0A3R7MDE3 | Trypanosoma rangeli | 44% | 96% |
A0A3S5H6B1 | Leishmania donovani | 100% | 100% |
A4H5J1 | Leishmania braziliensis | 75% | 99% |
A5WW08 | Danio rerio | 29% | 82% |
D0A993 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 94% |
E9AML5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4QI21 | Leishmania major | 94% | 100% |
Q5FWP4 | Xenopus laevis | 30% | 84% |
Q5RF77 | Pongo abelii | 28% | 92% |
Q6P256 | Xenopus tropicalis | 29% | 84% |
Q810L3 | Mus musculus | 29% | 79% |
Q96EP1 | Homo sapiens | 30% | 79% |
V5DJC2 | Trypanosoma cruzi | 44% | 84% |